Biomarkers for predicting response to regional chemo-immunotherapy in liver metastases from colorectal carcinoma

International Journal of Immunopharmacology

Volumn 19, Issue 9-10, 1997, Pages 481-485

  Zaloudik, J ^a   Vagunda, V ^a   Drahokoupilova, M ^a   Janakova, L ^a   Talac, R ^a   Kalabis, J ^a   Sheard, M ^a  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

Colorectal carcinoma; DNA ploidy; Liver metastases; P53 protein

Indexed keywords

BIOLOGICAL MARKER; DOXORUBICIN; FLUOROURACIL; HEBERON ALPHA N; MITOMYCIN C; ONCOPROTEIN; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT INTERLEUKIN 2; UNCLASSIFIED DRUG;

ANEUPLOIDY; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONFERENCE PAPER; DIPLOIDY; DRUG RESPONSE; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAARTERIAL DRUG ADMINISTRATION; LIVER METASTASIS; PLOIDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DNA, NEOPLASM; GENE EXPRESSION; GENETIC MARKERS; HUMANS; IMMUNOTHERAPY; INJECTIONS, INTRALESIONAL; LIVER NEOPLASMS; PLOIDIES; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031224884     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(97)00081-7     Document Type: Conference Paper

References (29)

1. Benhattar, J., Cerotini, J. P., Saraga, E., Metthez, G. and Givel, J. C. (1996) p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas. Int. J. Cancer, 69, 190-192.
2. Caruso, M. L., Valentini, A. M., Armentano, R. and Pirrelli, M. (1995) P-170 glycoprotein expression in gastric and colorectal carcinomas and normal mucosa. An immunocytochemical study. In Vivo, 9, 133-138.
3. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L. and Wyllie, A. H. (1993) Thymocyte apoptosis induced by p53-dependent and -independent pathways. Nature (Lond.), 362, 849-852.
4. Debatin, K. M. (1997) Cytotoxic drugs, programmed cell death, and the immune system : defining new roles in an old play. J. Natl. Cancer Inst., 89, 750-751.
5. Doglioni, C., Pelosio, P., Laurino, L., Macri, E., Meggiolaro, E., Favretti, F. and Barbareschi, M. (1996) p21/WAF1/CIP1 expression in normal mucosa and in adenomas and adenocarcinomas of the colon : its relationship with differentiation. J. Pathology, 179, 248-253.
6. Fishel, R. (1996) Genomic instability, mutator, and the devlopment of cancer : is there role for p53? J. Natl. Cancer Inst., 88, 608-609.
7. Fontanini, G., Pinitore, R. and Bigini, D. (1992) Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen (PCNA) and comparison with Ki-67 and DNA flow cytometry data. Am. J. Pathol., 141, 1285-1290.
8. Graeber, T. G., Peterson, J. F., Tsai, M., Monica, K., Fornace, A. J. and Giaccia, A. J. (1994) Hypoxia induces accumulation of p53 protein, but activation of G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol., 14, 6264-6277.
9. Hammarberg, C., Tribukait, B. and Ohman, U. (1986) Earkly effects of preoperative irradiation upon the cell cycle composition in rectal adenocarcinoma. A flow cytometric DNA investigation. Acta Radiol. Oncol., 25, 45-46.
10. Hedley, D. W., Friedlander, M. L. and Taylor, I. W. (1983) Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometer. J. Cytochem. Histochem., 31, 1333-1336.
11. Jones, D. J., Zaloudik, J., James, R. D., Haboubi, N., Moore, M. and Schofield, P. (1989) Predicting local recurrence of carcinoma of the rectum after preoperative radiotherapy and surgery. Br. J. Surgery, 76, 1172-1175.
12. Kahlenberg, M. S., Stoler, D. L., Basik, M., Petrelli, N. J., Rodriguez-Bigas, M., Anderson, G. R. (1996) p53 tumor supressor gene status and the degreee of genomic instability in sporadic cotorectal cancers. J. Natl. Cancer Inst., 88, 1665-1670.
13. Kapitanovic, S., Spaventi, R., Poljak, L., Kapitanovic, M., Pavelic, Z. P., Gluckman, J. L., Spaventi, S. and Pavelic, K. (1994) High c-erb-2 protein level in colorectal adenocarcinomas correlates with clinical parameters. Cancer Detect. Prev., 18, 97-101.
14. Kemeny, N., Daly, J. and Reichman, B. (1987) Intra-hepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Am. Intern. Med., 107, 59-65.
15. Link, K. H., Pillasch, J., Weindel, M., Formentini, A., Safi, F., Limmer, J. and Beger, H. G. (1997) Development of regional chemotherapy in nonresectable colorectal liver metastases. Rationale for a randomized trial. Proc. 7th Int. Congress on Anti-Cancer Treatment, Paris, 95, 164.
16. Liver Infusion Meta-Analysis Group (1997) Portal vein chemotherapy for colorectal cancer : a meta-analysis of 4000 patients in 10 studies. J. Natl. Cancer Inst., 89, 497-505.
17. Lygidakis, N. J., Savanis, G. and Pothoulakis, E. (1994) Transarterial locoregional immunostimulation and chemotherapy in patients with unresectable secondary liver tumors. Anticancer Res., 14, 1351-1356.
18. Makino, M., Shira, H., Sugamura, K., Kimura, O., Maeta, M., Itoh, H. and Kaibara N. (1996) Increased induction of apoptosis of human colorectal cancer cells after preoperative treatment with 5-fluorouracil. Oncology Reports, 3, 281-285.
19. Mavligit, G. M., Zukiwski, A. A. and Gutterman, J. U. (1990) Splenic versus hepatic artery infusion of interleukin-2 in patients with liver metastases. J. Clin. Oncol., 8, 319-324.
20. McMurrick, P. J. and Nelson, H. (1997) Liver-directed therapies for gastrointestinal malignancies. Current Opinion in Oncology, 9, 367-372.
21. Meta-Analysis Group in Cancer (1996) Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J. Natl. Cancer Inst., 88, 252-258.
22. Micheau, O., Solary, E., Hammann, A., Martin, F. and Dimanche-Boitrel, M. T. (1997) Sensitization of cancer cells treated with cytotoxic drugs to Fas-mediated cytotoxicity. J. Natl. Cancer Inst., 89, 783-789.
23. Rabinovich, P. S. (1995) Analysis of flow cytometric DNA histograms. In : Cell growth and apoptosis, ed. G. P., Studzinski, pp. 45-58. Oxford University Press, New York.
24. Rew, D. A., Karkera, R., Mullee, M. A., Julious, S. A. and Wilson, G. D. (1996) The flow cytometric analysis of total p53 protein content and proliferation indices in colorectal cancer, in relation to clinical outcome. Eur. J. Surg. Oncol., 22, 508-515.
25. Saeki, T., Salomon, D. S., Johnson, G. R., Gullick, W. J., Mandai, K., Yamagami, K., Moriwaki, S., Tanada, M., Takashima, S. and Tahara, E. (1995) Association of epidermal growth factor-related peptides and type I receptor tyrosine kinase receptors with prognosis of human colorectal carcinomas. Jpn. J. Clin. Oncol., 25, 240-249.
26. Suwanagool, P., Parichatikanond, P. and Maeda, S. (1993) Expression of c-erbB-2 oncoprotein in primary human tumors : an immunohistochemistry study. Asian Pac. J. Allergy Immunol., 11, 119-122.
27. Witzig, T. E., Loprinzi, C. L. and Gonchoroff, N. J. (1991) DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal carcinoma. Cancer, 68, 879-888.
28. Zaloudik, J., Moore, M. and Hasleton, P. (1988) The DNA content of colorectal carcinomas : an analysis of the heterogeneity of aneuploidy and correlation with immunopathological parameters. Neoplasma, 35, 389-401.
29. Zaloudik, J., Karasek, P., Kocak, I., Fait, V. and Talac, R. (1996) Interleukin-2 in regional chemo-immunotherapy of liver tumors (in Czech). Klinicka onkologie, 9, 109-114.